Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
NCT07455383
- Conditions
- Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +10 more
- Locations
-
- Alkermes Investigational Site Cullman, Alabama, United States
- Alkermes Investigational Site Los Angeles, California, United States
- Alkermes Investigational Site Boulder, Colorado, United States
- Alkermes Investigational Site Brandon, Florida, United States